tykhr
sign in
free sign up
Tarsus Pharmaceuticals Inc
Biotechnology
Healthcare
TARS
38.38 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
43.59
52 week high
56.94
high
46.31
52 week low
21.54
low
40.38
growth
39.17 %
previous Close
44.63
P/E ratio
market cap
2.10 B
div yield
0
usd
Sep 2024
qoq
revenue
48.12 M
17.90 %
net incoming
-23.42 M
29.65 %
eps
0.00 %
30.68 %
eps surprise
35.11 %
net profit margin
-48.67 %
32.00 %
operating incoming
-25.16 M
24.44 %
net change in cash
-4.89 M
61.26 %
cash on hand
176 M
-2.70 %
cost of revenue
3.24 M
7.92 %
top